Silver Spring, MD
June 27, 2018
On June 27, the U.S. Food and Drug Administration’s Commissioner Scott Gottlieb convened an Online Opioid Summit. The Summit brought together Internet stakeholders, government entities, academic researchers, and advocacy groups to discuss ways to collaboratively take stronger action in combatting the opioid crisis by reducing the availability of illicit opioids online.
Fight the Fakes International Meeting
Brussels, Belgium
October 23-25, 2017
ASOP Global’s Mike Isles was among the Fight the Fakes partners representing healthcare professionals, academia, NGOs, the generic and research-based pharmaceutical industry, healthcare distributors, and consumer protection organizations who met in Brussels to work on their future plans to raise awareness of the widespread sale and use of falsified medicines across the world and the dangers associated with these fake products.
Washington, DC
October 11, 2017
ASOP Global’s Executive Director, Libby Baney, presented the 2017 Global Patient Safety Champion Awards to the Honorable Michael C. Burgess, MD (R-TX-26), Chairman, House Energy and Commerce Subcommittee on Health; the Honorable Eugene Green (D-TX-29), Ranking Member, House Energy and Commerce Subcommittee on Health and the National Association of Boards of Pharmacy (NABP) at a Capitol Hill reception in Washington, DC.
Libby Baney and the Honorable Eugene Green
(D-TX-29)
Libby Baney and Marty Allain, NABP
Libby Baney and the Honorable Michael C. Burgess, MD (R-TX-26)
The Office of the U.S. Trade Representative (USTR) annually releases its Special 301 Report on the adequacy and effectiveness of IP rights protection by U.S. trading partners. Conducted under the auspices of the Special 301 program, the 2017 Notorious Markets List identifies online and physical marketplaces that reportedly engage in and facilitate substantial copyright piracy and trademark counterfeiting. ASOP Global submitted comments in response to USTR’s request for “examples of online and physical notorious markets, including foreign trade zones that allegedly facilitate substantial trademark counterfeiting and copyright piracy.”
June 29, 2017
Paris, France
The Alliance for Safe Online Pharmacies (ASOP Global) and the Alliance for Safe Online Pharmacy (ASOP EU) hosted the fifth Best Practice Sharing Workshop in Paris, France on June 29. ASOP Global’s Executive Director, Libby Baney, ASOP EU’s Mike Isles and Klaus Gritschneder, and NABP’s Policy and Communications Director, Melissa Madigan were joined by 20 EU member states and not-for-profit organizations where they discussed the need for more public awareness programs about falsified medicines like those previously conducted by ASOP Global in the U.S. and ASOP EU, as well as the “Common Logo”, which must appear on every online pharmacy selling medicine in Europe, and the latest progress relating to NABP’s .pharmacy top level domain (TLD) initiative.
Left to Right –
Hanne Hanken (Norway); Quentin Duteil (Fondation Chirac); Monika Macisowicz (Poland); Marion Barreau (IRACM); Klaus Gritschneder (ASOP EU); Mike Isles (ASOP EU); Lynda Scammell (UK); Sammy Kohli (Denmark); Sasa Polovic (Croatia); Melissa Madigan (NABP); Alain Denis (Belgium); Philippe de Buck (Belgium); Libby Baney (ASOP Global); Felicia Vaz (Fight the Fakes); Paul Brewer (UK); Aline Plancon (FMEDs Programme)
2017 European Association of Clinical Pharmacology and Therapeutics Congress (EACPT)
June 26, 2017
Prague, Czech Republic
Mike Isles, executive director of ASOP EU, and other international experts led the Global Health/Access to Safe Medicines Session during the 2017 European Association of Clinical Pharmacology and Therapeutics (EACPT) Congress, which was held in Prague from June 24-27. Watch the panel discussion featuring the experts listed below.
Pavle Zelic, Medicines and Medical Devices Agency, Serbia
Josez Glasa, Slovak Medical University, Slovakia
Mike Isles, ASOP EU and EAASM
Prof. Donald Singer, Clinical Pharmacologist, EACPT
and President, Fellowship of Postgraduate Medicine
June 5, 2017
Quebec City, Canada
May 20, 2017
Orlando, FL
ASOP Global’s Executive Director, Libby Baney, and NABP’s Policy and Communications Director, Melissa Madigan and Ronald F.Guse, an NABP .pharmacy Canadian consultant, member of the board of the Canadian Patient Safety Institute and former Manitoba Provincial Regulator were the speakers at the first Canadian Internet Drug Sales Roundtable, which was held during NABP’s 113th annual conference in Orlando, FL.
Congress is set to consider new legislation that would legalize importation of prescription medicines from foreign countries outside the jurisdiction of the U.S. Food and Drug Administration (FDA). Such a policy would put Americans at increased risk of receiving counterfeit or otherwise unsafe medications, including controlled substances offered by illegal foreign online pharmacies without a prescription, contributing to the opioid epidemic in the U.S.
April 28, 2017
ASOP Global and The Pew Charitable Trusts held a briefing on Capitol Hill to discuss illegal online pharmacies; protections provided by the Drug Supply Chain Security Act; risks associated with legalizing importation of prescription medicines from Canada and other countries; and consequences for patients who are exposed to unsafe products.